Concurrent To Twill Acquisition Deal, Dariohealth Priced $22.4M Equity Financing
Portfolio Pulse from Benzinga Newsdesk
DarioHealth Corp. has announced a $22.4 million private placement of convertible preferred stock at market price under Nasdaq rules, alongside its acquisition of Twill. The financing involves issuing shares at $1,000 each, with conversion prices of $2.02 and $2.14, aiming to raise gross proceeds of $22.4 million.
February 21, 2024 | 11:06 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
DarioHealth Corp. is raising $22.4 million through a private placement of convertible preferred stock, coinciding with its acquisition of Twill. The shares are priced at $1,000 each, with conversion prices set at $2.02 and $2.14.
The equity financing could provide DarioHealth with necessary capital for its operations and growth, potentially making it an attractive investment. The association with the Twill acquisition suggests strategic expansion, possibly boosting investor confidence and stock price in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100